Ro-44-3888

Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.

Ro-44-3888
Identifiers
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC18H24N4O5
Molar mass376.413 g·mol−1
3D model (JSmol)

See also

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.